Melisa Hammett
Family · Gaffney, SCNPI 1518443076
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,267 of the $10,194 with a category attached, or 81.1%. Organon accounts for 63.2% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2024 at $4,620 and has fallen 53.0% since, to $2,172 in 2025. Among family clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 68 payments — averaging $149.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$6K
- Afaxys, Inc.$3K
- AbbVie$304
- Lucid Diagnostics Inc.$177
- Novartis$108
- Alkermes, Inc.$43
- plus $294 from 13 others
What the payments were for
- Speaking & faculty fees$8,26781%
- Travel & lodging$6476%
- Food & beverage$1,27913%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 10 | $6,444 |
| Afaxys, Inc. | 4 | $2,823 |
| AbbVie | 23 | $304 |
| Lucid Diagnostics Inc. | 4 | $177 |
| Novartis | 6 | $108 |
| Alkermes, Inc. | 2 | $43 |
| Amgen | 3 | $40 |
| AstraZeneca | 2 | $35 |
| Pfizer | 2 | $33 |
| Astellas Pharma US Inc | 2 | $30 |
| Exact Sciences | 2 | $27 |
| Corcept Therapeutics | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Johnson & Johnson | 1 | $15 |
| Indivior Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $12 |
| Corium, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$4,180
- Medroxyprogesterone$2,473
- Chateal$350
- Aubra$350
- Econtra One-Step$350
How this compares
$10,194 in reported general payments places this provider in the 95th percentile of 3,248 family providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 55 | $68,016 |
| OzempicSemaglutide | 45 | $49,355 |
| TrulicityDulaglutide | 26 | $38,316 |
| TymlosAbaloparatide | 11 | $29,337 |
| JardianceEmpagliflozin | 26 | $26,214 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 19 | $18,112 |
| EliquisApixaban | 22 | $17,059 |
| XareltoRivaroxaban | 12 | $16,451 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 12 | $15,921 |
| InvokanaCanagliflozin | 12 | $8,213 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 92 | $4,329 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $3,084 |
| Gabapentin | 125 | $2,362 |
| Atorvastatin Calcium | 231 | $2,112 |
| Duloxetine Hcl | 60 | $1,210 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $35 | $68,01655 claims |
| Lilly USA, LLCTrulicity | $12 | $38,31626 claims |
| Johnson & JohnsonXarelto, Invokana | $15 | $24,66424 claims |
| PfizerEliquis | $33 | $17,05922 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,248 family providers in South Carolina.
Other family in Gaffney
- Tonya ReidGaffney$12K
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.